"Kliininen lääketutkimus"

During the past decade, CRST, Clinical Research Services Turku conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CRST, Clinical Research Services Turku" #1 sponsor was "Orion Corporation, Orion Pharma" with 11 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Biogen" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CRST, Clinical Research Services Turku" #1 collaborator was "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "CRST Oy" with 1 trials as a collaborator, "Janssen Pharmaceuticals" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator and "Julius Clinical" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "CRST, Clinical Research Services Turku" are "Alzheimer's Disease" (11 trials), "Alzheimer Disease" (4 trials), "Healthy" (3 trials), "Parkinson's Disease" (3 trials) and "Healthy Volunteers" (2 trials). Many other conditions were trialed in "CRST, Clinical Research Services Turku" in a lesser frequency.

Most popular intervention types in "CRST, Clinical Research Services Turku" are "Drug" (27 trials), "Other" (6 trials), "Biological" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "ORM-12741" (4 trials), "Gantenerumab" (2 trials), "ORM-12741 IR" (2 trials) and "ORM-12741 MR A" (2 trials). Other intervention names were less common.

The vast majority of trials in "CRST, Clinical Research Services Turku" are 28 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "CRST, Clinical Research Services Turku". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in CRST, Clinical Research Services Turku, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in CRST, Clinical Research Services Turku, 13 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".